Optimizing Platelet GPVI Inhibition versus Haemostatic Impairment by the Btk Inhibitors Ibrutinib, Acalabrutinib, ONO/GS-4059, BGB-3111 and Evobrutinib.
- Resource Type
- Article
- Source
- Thrombosis & Haemostasis; 2019, Vol. 119 Issue 3, p397-406, 10p
- Subject
- Language
- ISSN
- 03406245